{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:49:19Z","timestamp":1778586559517,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00428-024-03901-w","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:45:45Z","timestamp":1724345145000},"page":"729-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of non-coding and coding DNA mutations in flat urothelial lesions: biological implications and insights"],"prefix":"10.1007","volume":"486","author":[{"given":"Fidele Y.","family":"Musangile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibu","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Sagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurina","family":"Mikasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoma","family":"Higashine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyoshi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-3051","authenticated-orcid":false,"given":"Shin-ichi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"issue":"3","key":"3901_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3901_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","volume":"75","author":"JI Warrick","year":"2019","unstructured":"Warrick JI, Sj\u00f6dahl G, Kaag M, Raman JD, Merrill S, Shuman L et al (2019) Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants. Eur Urol 75(1):18\u201322","journal-title":"Eur Urol"},{"issue":"5","key":"3901_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","volume":"17","author":"JJ Meeks","year":"2020","unstructured":"Meeks JJ, Al-Ahmadie H, Faltas BM, Taylor JA, Flaig TW, DeGraff DJ et al (2020) Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nat Rev Urol 17(5):259\u2013270","journal-title":"Nat Rev Urol"},{"issue":"2","key":"3901_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234\u2013241","journal-title":"Eur Urol"},{"issue":"1","key":"3901_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD (2015) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 15(1):25\u201341","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3901_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100120","volume":"36","author":"FY Musangile","year":"2023","unstructured":"Musangile FY, Matsuzaki I, Iwamoto R, Sagan K, Nishikawa M, Mikasa Y et al (2023) Targeted next-generation sequencing of flat urothelial lesions reveals putative pathobiological pathways, potential biomarkers, and rational therapeutic targets. Mod Pathol 36(5):100120","journal-title":"Mod Pathol"},{"issue":"6","key":"3901_CR7","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.3892\/or.2017.5607","volume":"37","author":"D Wu","year":"2017","unstructured":"Wu D, Niu X, Tao J, Li P, Lu Q, Xu A et al (2017) MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. Oncol Rep 37(6):3502\u20133508","journal-title":"Oncol Rep"},{"issue":"1","key":"3901_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-019-1040-0","volume":"18","author":"Q Lu","year":"2019","unstructured":"Lu Q, Liu T, Feng H, Yang R, Zhao X, Chen W et al (2019) Circular RNA circSLC8A1 acts as a sponge of miR-130b\/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer 18(1):111","journal-title":"Mol Cancer"},{"issue":"4","key":"3901_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s13577-023-00915-5","volume":"36","author":"DRA Sanya","year":"2023","unstructured":"Sanya DRA, On\u00e9sime D (2023) Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer. Hum Cell 36(4):1343\u20131372","journal-title":"Hum Cell"},{"issue":"6","key":"3901_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000509957","volume":"87","author":"D Li","year":"2020","unstructured":"Li D, Zhong S, Zhu Z, Jiang X, Zhang J, Gu J et al (2020) LncRNA MAFG-AS1 promotes the progression of bladder cancer by targeting the miR-143-3p\/COX-2 axis. Pathobiology 87(6):345\u2013355","journal-title":"Pathobiology"},{"issue":"6225","key":"3901_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1126\/science.1260200","volume":"347","author":"S Borah","year":"2015","unstructured":"Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB et al (2015) Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science 347(6225):1006\u201310","journal-title":"Science"},{"issue":"43","key":"3901_CR12","doi-asserted-by":"publisher","first-page":"17426","DOI":"10.1073\/pnas.1310522110","volume":"110","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C et al (2013) TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci U S A 110(43):17426\u201317431","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3901_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL et al (2022) European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol 81(1):75\u201394","journal-title":"Eur Urol"},{"issue":"1","key":"3901_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S et al (2017) Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 19(1):4\u201323","journal-title":"J Mol Diagn"},{"issue":"5","key":"3901_CR15","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.celrep.2014.04.038","volume":"7","author":"I Nordentoft","year":"2014","unstructured":"Nordentoft I, Lamy P, Birkenkamp-Demtr\u00f6der K, Shumansky K, Vang S, Hornsh\u00f8j H et al (2014) Mutational context and diverse clonal development in early and late bladder cancer. Cell Rep 7(5):1649\u20131663","journal-title":"Cell Rep"},{"issue":"1","key":"3901_CR16","doi-asserted-by":"publisher","first-page":"e003087","DOI":"10.1136\/jitc-2021-003087","volume":"10","author":"M Zheng","year":"2022","unstructured":"Zheng M (2022) Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better. J Immunother Cancer 10(1):e003087","journal-title":"J Immunother Cancer"},{"issue":"7471","key":"3901_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C et al (2013) Mutational landscape and significance across 12 major cancer types. Nature 502(7471):333\u2013339","journal-title":"Nature"},{"issue":"7739","key":"3901_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y et al (2019) Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565(7739):312\u2013317","journal-title":"Nature"},{"issue":"6512","key":"3901_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.aba8347","volume":"370","author":"ARJ Lawson","year":"2020","unstructured":"Lawson ARJ, Abascal F, Coorens THH, Hooks Y, O\u2019Neill L, Latimer C et al (2020) Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370(6512):75\u201382","journal-title":"Science"},{"issue":"9","key":"3901_CR20","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/ijc.24619","volume":"125","author":"K Zieger","year":"2009","unstructured":"Zieger K, Marcussen N, Borre M, \u00d8rntoft TF, Dyrskj\u00f8t L (2009) Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development. Int J Cancer 125(9):2095\u20132103","journal-title":"Int J Cancer"},{"issue":"12","key":"3901_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100472","volume":"2","author":"CD Hurst","year":"2021","unstructured":"Hurst CD, Cheng G, Platt FM, Castro MAA, Marzouka NS, Eriksson P et al (2021) Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight. Cell Rep Med 2(12):100472","journal-title":"Cell Rep Med"},{"key":"3901_CR22","doi-asserted-by":"crossref","unstructured":"Lee R, Droller MJ (2000) The natural history of bladder cancer. Implications for therapy. Urol Clin North Am 27(1):1\u201313, vii","DOI":"10.1016\/S0094-0143(05)70229-9"},{"issue":"6","key":"3901_CR23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","volume":"72","author":"EJ Pietzak","year":"2017","unstructured":"Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S et al (2017) Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. Eur Urol 72(6):952\u2013959","journal-title":"Eur Urol"},{"issue":"3","key":"3901_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1158\/1078-0432.CCR-18-1001","volume":"25","author":"Q Li","year":"2019","unstructured":"Li Q, Damish AW, Frazier Z, Liu D, Reznichenko E, Kamburov A et al (2019) ERCC2 helicase domain mutations confer nucleotide excision repair deficiency and drive cisplatin sensitivity in muscle-invasive bladder cancer. Clin Cancer Res 25(3):977\u2013988","journal-title":"Clin Cancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-024-03901-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-024-03901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:23:09Z","timestamp":1745389389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-024-03901-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1007\/s00428-024-03901-w","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided informed consent prior to inclusion in this study. In cases where obtaining informed consent was not feasible, an opt-out informed consent protocol for the use of participant data for research purposes was employed. This consent procedure, along with the study design, underwent review and received approval by the Institutional Review Board of Wakayama Medical University under approval number 3263, on August 21, 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}